UK Commits $1 Billion To Moderna mRNA Flu Vaccine

According to John Campbell, Ph.D., who reported on his YouTube show, the UK has committed $1 billion to the development of Moderna mRNA flu vaccine, despite the fact that the vaccine is still in very early clinical trials.

The National Institutes of Health is running a Phase 1 clinical trial on an experimental mRNA universal influenza vaccine developed by researchers at the National Institute of Allergy and Infectious Diseases’ (NIAID) Vaccine Research Center.

Although the vaccine is only...

Subscribe to view this content.

 
Do you have a tip or sensitive material to share with GGI? Are you a journalist, researcher or independent blogger and want to write for us? You can reach us at [email protected].